Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • nilmot13
    Member
    • Jan 2011
    • 19

    Simple Bowtie question

    Hi,

    I've been playing around with Bowtie on Galaxy platform and I would like to ask some very simple question really to confirm my understanding to the Bowtie parameters.

    My aim for the mapping is to get the best sequencing alignment to a custome genome.

    These are the parameter I've used:

    Single-end
    -n = 2
    -e = 70
    --nomaqround = round to nearest 10
    -y
    -a
    --best
    --maxbts = 800
    --strata

    Will the parameters I've set gave me a single alignment per sequence read and also ensure it's 'uniqueness/stringency'?

    If anyone could help that would be fantastic.

    Many thanks
  • tianyub836
    Member
    • Apr 2011
    • 23

    #2
    try option "-m 1"

    Comment

    • 770349688
      Junior Member
      • Feb 2012
      • 1

      #3
      TMM normalization

      Hello:
      it is said that TMM is a normalization in RNA-seq,and I have learn it for a long time。But I don‘t understand it so far。Can you tell me how does it perform?And I would be gratefull if you could give me an example ?

      Comment

      • nilmot13
        Member
        • Jan 2011
        • 19

        #4
        Originally posted by tianyub836 View Post
        try option "-m 1"
        Hi,

        I didn't use -m = 1 beause it will reduce the mapping coverage of some reads. E.g in the ribisomal RNA region there gene cluster are very highly conserved and our lab is still interested about its coverage.

        What I was really looking for is, would the parameter I've set gave me a stringent mapping result? i.e. less mismatches and poor quality reads being mapped.

        Cheers

        Comment

        • oxydeepu
          Member
          • Jul 2011
          • 41

          #5
          A simple question about bowtie output

          Hi all..

          i have a small doubt. In the output of bowtie, how to figure out mismatches. +ve is fine., but in negative there is reverse complementation thats what is giving me a confusion.
          Please help as soon as possible.
          Thank you in advance.

          Deepak

          Comment

          • nilmot13
            Member
            • Jan 2011
            • 19

            #6
            Hi Deepak, what exactly are the problems that you are encounting?

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            31 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            214 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            79 views
            0 reactions
            Last Post SEQadmin2  
            Working...